Achieving control of resistant hypertension:Not just the number of blood pressure medications

Jian Huang; Kara Schmidt; Steven Tringali; William Kelley

文献导航

搜索文章

搜索思路

钛学术文献服务平台 \
学术期刊 \
综合期刊 \
其它期刊 \
世界高血压杂志期刊 \
Achieving control of resistant hypertension:Not just the number of blood pressure medications

Achieving control of resistant hypertension:Not just the number of blood pressure medications

作者：

Jian Huang Kara Schmidt Steven Tringali William Kelley

基本信息来源于合作网站，原文需代理用户跳转至来源网站获取

Resistant

HYPERTENSION

Pseudoresistance

MINERALOCORTICOID

receptor

antagonists

Device-based

HYPERTENSION

treatment

Renal

DENERVATION

Carotid

BARORECEPTOR

activation

therapy

Central

ARTERIOVENOUS

anastomosis

摘要：

Resistant hypertension (RH) has a prevalence of around 12% and is associated with an increased risk of cardiovascular disease,progression to end-stage renal disease,and even mortality.In 2017,the American College of Cardiology and American Heart Association released updated guidelines that detail steps to ensure proper diagnosis of RH,including the exclusion of pseudoresistance.Lifestyle modifications,such as low salt diet and physical exercise,remain at the forefront of optimizing blood pressure control.Secondary causes of RH also need to be investigated,including screening for obstructive sleep apnea.Notably,the guidelines demonstrate a major change in medication management recommendations to include mineralocorticoid receptor antagonists.In addition to advances in medication optimization,there are several device-based therapies that have been showing efficacy in the treatment of RH.Renal denervation therapy has struggled to show efficacy for blood pressure control,but with a redesigned catheter device,it is once again being tested in clinical trials.Carotid baroreceptor activation therapy (BAT) via an implantable pulse generator has been shown to be effective in lowering blood pressure both acutely and in longterm follow up data,but there is some concern about the safety profile.Both a second-generation pulse generator and an endovascular implant are being tested in new clinical trials with hopes for improved safety profiles while maintaining therapeutic efficacy.Both renal denervation and carotid BAT need continued study before widespread clinical implementation.Central arteriovenous anastomosis has emerged as another possible therapy and is being actively explored.The ongoing pursuit of blood pressure control is a vital part of minimizing adverse patient outcomes.The future landscape appears hopeful for helping patients achieve blood pressure goals not only through the optimization of antihypertensive medications but also through device-based therapies in select individuals.

内容分析

关键词云

关键词热度

相关文献

推荐文献

根据相关规定，获取原文需跳转至原文服务方进行注册认证身份信息

完成下面三个步骤操作后即可获取文献，阅读后请点击下方页面【继续获取】按钮

钛学术文献服务平台

学术出版新技术应用与公共服务实验室出品

原文合作方

获取文献流程

1.访问原文合作方请等待几秒系统会自动跳转至登录页，首次访问请先注册账号，填写基本信息后，点击【注册】

2.注册后进行实名认证，实名认证成功后点击【返回】

3.检查邮箱地址是否正确，若错误或未填写请填写正确邮箱地址，点击【确认支付】完成获取，文献将在1小时内发送至您的邮箱

*若已注册过原文合作方账号的用户，可跳过上述操作，直接登录后获取原文即可

点击【获取原文】按钮，跳转至合作网站。

首次获取需要在合作网站进行注册。

注册并实名认证，认证后点击【返回】按钮。

确认邮箱信息，点击【确认支付】，订单将在一小时内发送至您的邮箱。

* 若已经注册过合作网站账号，请忽略第二、三步，直接登录即可。

期刊分类
期刊（年）
期刊（期）
期刊推荐

其它

世界高血压杂志2019 世界高血压杂志2018 世界高血压杂志2017 世界高血压杂志2016 世界高血压杂志2015 世界高血压杂志2014 世界高血压杂志2013 世界高血压杂志2012 世界高血压杂志2011

世界高血压杂志2019年第3期世界高血压杂志2019年第2期世界高血压杂志2019年第1期

按字母查找期刊：

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
其他

联系合作广告推广: shenyukuan@paperpass.com

篇名	Achieving control of resistant hypertension:Not just the number of blood pressure medications
来源期刊	世界高血压杂志	学科	医学
关键词	Resistant HYPERTENSION Pseudoresistance MINERALOCORTICOID receptor antagonists Device-based HYPERTENSION treatment Renal DENERVATION Carotid BARORECEPTOR activation therapy Central ARTERIOVENOUS anastomosis
年，卷（期）	2019,（1）	所属期刊栏目
研究方向		页码范围	1-16
页数	16页	分类号	R
字数		语种
DOI